Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Estradiol for Bleeding in Implant Users
NCT04933240Phase 4Withdrawn
- Sponsor
- Virginia Commonwealth University
- Start
- May 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen, sponsored by Virginia Commonwealth University. Planned start May 2022; status: withdrawn.
02
Drugs
tamoxifen
Beyond the preview
Go deeper on NCT04933240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04933240.